Preprint · 2026 · Open access

Population-level oral health implications of GLP-1 receptor agonists: a scoping review of emerging evidence and public health preparedness

Abdullah Bokhary

Published 18 July 2026 · DOI 10.17605/osf.io/93ehj

Open full textView at the publisherCite this paper

In brief

“Population-level oral health implications of GLP-1 receptor agonists: a scoping review of emerging evidence and public health preparedness” is a 2026 preprint by Abdullah Bokhary. OpenAlex counts 0 citations as of 18 November 2026. It is open access under a public domain licence: the full text is free to read.

Citations
0
Authors
1

Abstract

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are being adopted at population scale for type 2 diabetes and obesity, and their exposed population is widening to include large numbers of adults without diabetes. Their oral and dental implications have, to date, been considered almost entirely from a clinical standpoint rather than a population or public health perspective. This scoping review maps the extent, range and nature of the emerging evidence on the oral and dental implications of GLP-1RAs and examines it through a dental public health lens (population burden, medical-dental integration, equity, and surveillance), to identify what is known, where the evidence is concentrated, and where the gaps lie for a proactive public health response. The review follows the Arksey and O'Malley framework, refined by Levac and colleagues and by the JBI methodology for scoping reviews, and is reported per PRISMA-ScR. It charts human evidence (primary observational studies, clinical trials, case reports and series, pharmacovigilance and disproportionality analyses, reviews, clinical guidance, commentaries, and relevant grey literature) alongside preclinical mechanistic studies, which are charted separately. Eligible records concern humans of any age exposed to a GLP-1RA or a dual GIP/GLP-1 receptor agonist for any indication, and any oral or dental outcome, mechanism, model of care, policy consideration, equity dimension, or surveillance/pharmacovigilance signal. Information sources are MEDLINE (via PubMed), the OpenAlex bibliographic index, and preprints (medRxiv, bioRxiv, OSF, SSRN, Research Square). Planned analytical outputs are an evidence map (oral outcome x evidence type x volume), a matrix of dental-public-health-dimension coverage across sources, and a conceptual framework linking population-scale prescribing to oral exposures, population burden and the integration, policy and surveillance responses required. Consistent with scoping review methodology, the objective is to map rather than appraise the evidence, and no formal risk-of-bias or certainty-of-evidence assessment is undertaken.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Bokhary, A. (2026). Population-level oral health implications of GLP-1 receptor agonists: a scoping review of emerging evidence and public health preparedness. https://doi.org/10.17605/osf.io/93ehj

MLA 9

Bokhary, Abdullah. “Population-level oral health implications of GLP-1 receptor agonists: a scoping review of emerging evidence and public health preparedness.” 2026. https://doi.org/10.17605/osf.io/93ehj.

Chicago

Bokhary, Abdullah. 2026. “Population-level oral health implications of GLP-1 receptor agonists: a scoping review of emerging evidence and public health preparedness.” https://doi.org/10.17605/osf.io/93ehj.

Harvard

Bokhary, A. (2026) ‘Population-level oral health implications of GLP-1 receptor agonists: a scoping review of emerging evidence and public health preparedness’. doi:10.17605/osf.io/93ehj.

IEEE

A. Bokhary, “Population-level oral health implications of GLP-1 receptor agonists: a scoping review of emerging evidence and public health preparedness,” 2026, doi: 10.17605/osf.io/93ehj.

BibTeX

@misc{bokhary2026population,
  title     = {{Population-level oral health implications of GLP-1 receptor agonists: a scoping review of emerging evidence and public health preparedness}},
  author    = {Bokhary, Abdullah},
  year      = {2026},
  doi       = {10.17605/osf.io/93ehj},
  url       = {https://doi.org/10.17605/osf.io/93ehj}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management

  • GLP-1 receptor agonists
  • oral health
  • dental health
  • type 2 diabetes
  • obesity
  • GIP/GLP-1 receptor agonist
  • medical-dental integration
  • health equity

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Bokhary, A. (2026). Population-level oral health implications of GLP-1 receptor agonists: a scoping review of emerging evidence and public health preparedness. https://doi.org/10.17605/osf.io/93ehj

How many times has this paper been cited?

0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: sign in and open the full text from this page.

Who wrote this paper?

Abdullah Bokhary.

What is the DOI of this paper?

10.17605/osf.io/93ehj, permanently at https://doi.org/10.17605/osf.io/93ehj. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.